Sunshine Biopharma, Inc. (SBFM)
1.12
-0.05
(-4.27%)
USD |
NASDAQ |
Sep 03, 16:00
1.13
+0.01
(+0.89%)
After-Hours: 19:06
Sunshine Biopharma Total Liabilities (Quarterly) : 6.095M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.095M |
| March 31, 2026 | 6.414M |
| December 31, 2025 | 7.041M |
| September 30, 2025 | 7.288M |
| June 30, 2025 | 6.280M |
| March 31, 2025 | 6.485M |
| December 31, 2024 | 7.060M |
| September 30, 2024 | 5.018M |
| June 30, 2024 | 5.811M |
| March 31, 2024 | 7.079M |
| December 31, 2023 | 6.140M |
| September 30, 2023 | 5.687M |
| June 30, 2023 | 5.300M |
| March 31, 2023 | 7.562M |
| December 31, 2022 | 7.918M |
| September 30, 2022 | 0.4802M |
| June 30, 2022 | 0.1047M |
| March 31, 2022 | 0.0952M |
| December 31, 2021 | 1.991M |
| September 30, 2021 | 3.676M |
| June 30, 2021 | 2.690M |
| March 31, 2021 | 2.943M |
| December 31, 2020 | 2.000M |
| September 30, 2020 | 1.105M |
| June 30, 2020 | 0.6658M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.7723M |
| December 31, 2019 | 0.8335M |
| September 30, 2019 | 0.8892M |
| June 30, 2019 | 0.9257M |
| March 31, 2019 | 1.459M |
| December 31, 2018 | 1.202M |
| September 30, 2018 | 1.060M |
| June 30, 2018 | 1.446M |
| March 31, 2018 | 1.503M |
| December 31, 2017 | 0.8308M |
| September 30, 2017 | 0.6099M |
| June 30, 2017 | 0.7806M |
| March 31, 2017 | 0.2845M |
| December 31, 2016 | 0.2741M |
| September 30, 2016 | 0.2767M |
| June 30, 2016 | 1.214M |
| March 31, 2016 | 1.186M |
| December 31, 2015 | 1.270M |
| September 30, 2015 | 0.4696M |
| June 30, 2015 | 0.4361M |
| March 31, 2015 | 0.3792M |
| December 31, 2014 | 0.531M |
| September 30, 2014 | 0.4566M |
| June 30, 2014 | 0.3823M |
| March 31, 2014 | 0.185M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 33.63M |
| Shareholders Equity (Quarterly) | 27.54M |
| Debt to Equity Ratio | 0.0246 |
| Current Ratio | 5.457 |
| Net Debt Paydown Yield | 1.03% |